SAN FRANCISCO, Feb. 16, 2021 /PRNewswire/ -- Kindred
Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company
focused on saving and improving the lives of pets, will present at
the BofA Securities Animal Health Virtual Summit on February 25.
Dr. Richard Chin, Chief Executive
Officer, will present via webcast at 10.50am ET and be available for virtual
one-on-one meetings. During this time, investors will have the
opportunity to discuss recent developments, study results from key
therapeutic programs in development, and upcoming milestones.
An archived version of the above webcast will be available for
30 days on the KindredBio website.
About Kindred Biosciences
Kindred Biosciences is a biopharmaceutical company developing
innovative biologics focused on saving and improving the lives of
pets. Its mission is to bring to pets the same kinds of safe and
effective medicines that human family members enjoy. The Company's
strategy is to identify targets that have already demonstrated
safety and efficacy in humans and to develop therapeutics based on
these validated targets for dogs and cats. KindredBio has a deep
pipeline of novel biologics in development across many therapeutic
classes, alongside state-of-the-art biologics manufacturing
capabilities and a broad intellectual property portfolio.
For more information, visit: www.kindredbio.com
Contact
Katja Buhrer
katja.buhrer@kindredbio.com
(917) 969-3438
View original content to download
multimedia:http://www.prnewswire.com/news-releases/kindred-biosciences-to-present-at-the-bofa-securities-animal-health-virtual-summit-301229317.html
SOURCE Kindred Biosciences, Inc.